We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Premier Biomedical Inc (PK) | USOTC:BIEI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0003 | 23.08% | 0.0016 | 0.0013 | 0.0016 | 0.0016 | 0.00135 | 0.00135 | 7,102,685 | 21:18:39 |
|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
SEC File No: 000-54563
|
|
Washington, D.C. 20549
|
CUSIP No: 74048 K 10 4
|
☐
|
|
Transition
report on Form 10-K
|
☐
|
|
Transition
report on Form 20-F
|
☐
|
|
Transition
report on Form 11-K
|
☐
|
|
Transition
report on Form 10-Q
|
☐
|
|
Transition
report on Form N-SAR
|
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
|
PART 1 -- REGISTRANT INFORMATION
|
|
Premier
Biomedical, Inc.
|
Full
Name of Registrant
|
|
Former
Name if Applicable
|
|
P.O.
Box 25
|
Address
of Principal Executive Office (
Street and Number)
|
|
Jackson
Center, PA 16133
|
City,
State and Zip Code
|
☒
|
|
(a) The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
|
(b) The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or a
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and
|
|
|
(c) The
accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
|
William
Hartman
|
814
|
786-8849
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
Premier
Biomedical, Inc.
|
(Name
of Registrant as Specified in Charter)
|
Date
|
November
14, 2018
|
By
|
/s/
William A. Hartman
|
|
|
|
William
A. Hartman
|
|
|
|
Chief
Executive Officer
|
1 Year Premier Biomedical (PK) Chart |
1 Month Premier Biomedical (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions